Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Nov;24(5):645–653. doi: 10.1111/j.1365-2125.1987.tb03224.x

Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.

M Scheinin 1, M Koulu 1, E Laurikainen 1, H Allonen 1
PMCID: PMC1386337  PMID: 2829953

Abstract

1. The hypokalaemia-inducing effects of two widely used inhaled antiasthmatic beta 2-adrenoceptor agonists, fenoterol and salbutamol, were compared in six healthy male volunteers. 2. Each drug was administered in three different doses, 400, 600 and 800 micrograms, which were repeated three times with 30 min intervals (total doses 1200, 1800 and 2400 micrograms in 1 h). The treatments were given at 1 week intervals in random order in a single-blind fashion. 3. The concentration of potassium in plasma was dose-dependently reduced by both drugs with peak effects 75-90 min after the first inhalations. The hypokalaemic effect of fenoterol was significantly greater than that of equal doses of salbutamol (average +/- s.d. reductions of 1.13 +/- 0.32 and 0.67 +/- 0.25 mEq l-1, respectively, after the highest doses, P less than 0.05). Concomitantly, decreases were noted in the amplitude of the T-wave on the ECG. 4. The concentration of cyclic AMP in plasma was measured and used as an indicator of systemic beta 2-adrenoceptor agonistic effects of the drugs. Increases in cAMP were a close mirror image of the drugs' effects on potassium in plasma. 5. Plasma renin activity, noradrenaline in plasma and heart rate were also dose-dependently increased by the treatments, whereas blood pressure remained unaltered. 6. While the clinical significance of hypokalaemia induced by inhaled beta 2-adrenoceptor sympathomimetics still is a matter of debate, our results point to possible differences between therapeutically equipotent doses of fenoterol and salbutamol in their propensity to cause hypokalaemia and other acute non-bronchial effects.

Full text

PDF
645

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cryer P. E., Rizza R. A., Haymond M. W., Gerich J. E. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism. 1980 Nov;29(11 Suppl 1):1114–1118. doi: 10.1016/0026-0495(80)90019-0. [DOI] [PubMed] [Google Scholar]
  2. D'Silva J. L. The action of adrenaline on serum potassium. J Physiol. 1934 Nov 12;82(4):393–398. doi: 10.1113/jphysiol.1934.sp003190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davis J. O., Freeman R. H. Mechanisms regulating renin release. Physiol Rev. 1976 Jan;56(1):1–56. doi: 10.1152/physrev.1976.56.1.1. [DOI] [PubMed] [Google Scholar]
  4. Endres P., Schnabel K. H., Ferlinz R. Die Beeinflussung des Plasmas cAMP durch inhalative und parenterale beta2-adrenerge Stimulatoren. Pneumonologie. 1976;SUPPL:171–175. [PubMed] [Google Scholar]
  5. Fairfax A. J., Rehahn M., Jones D., O'Malley B. Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects. Br J Clin Pharmacol. 1984 Feb;17(2):165–170. doi: 10.1111/j.1365-2125.1984.tb02332.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goldstein D. S., Feuerstein G., Izzo J. L., Jr, Kopin I. J., Keiser H. R. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci. 1981 Feb 2;28(5):467–475. doi: 10.1016/0024-3205(81)90139-9. [DOI] [PubMed] [Google Scholar]
  7. Grospietsch G., Fenske M., Girndt J., Uhlich E., Kuhn W. The renin-angiotensin-aldosterone system, antidiuretic hormone levels and water balance under tocolytic therapy with Fenoterol and Verapamil. Int J Gynaecol Obstet. 1980 May-Jun;17(6):590–595. doi: 10.1002/j.1879-3479.1980.tb00214.x. [DOI] [PubMed] [Google Scholar]
  8. Grossman S. H., Davis D., Gunnells J. C., Shand D. G. Plasma norepinephrine in the evaluation of baroreceptor function in humans. Hypertension. 1982 Jul-Aug;4(4):566–571. doi: 10.1161/01.hyp.4.4.566. [DOI] [PubMed] [Google Scholar]
  9. Haalboom J. R., Deenstra M., Struyvenberg A. Hypokalaemia induced by inhalation of fenoterol. Lancet. 1985 May 18;1(8438):1125–1127. doi: 10.1016/s0140-6736(85)92432-8. [DOI] [PubMed] [Google Scholar]
  10. Hjemdahl P., Akerstedt T., Pollare T., Gillberg M. Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand Suppl. 1983;515:45–53. [PubMed] [Google Scholar]
  11. Kucharczyk N., Segelman F. H. Drug level monitoring of antiasthmatic drugs. J Chromatogr. 1985 May 10;340:243–271. doi: 10.1016/0378-4347(85)80199-7. [DOI] [PubMed] [Google Scholar]
  12. Küng M. Parenteral adrenergic bronchodilators and potassium. Chest. 1986 Mar;89(3):322–323. doi: 10.1378/chest.89.3.322. [DOI] [PubMed] [Google Scholar]
  13. Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 1980 Dec;32(4):337–362. [PubMed] [Google Scholar]
  14. Lawford P., Dowd D. E., Palmer K. N. A comparison of the duration of action of fenoterol and salbutamol in asthma. Curr Med Res Opin. 1981;7(6):349–351. [PubMed] [Google Scholar]
  15. Leitch A. G., Clancy L. J., Costello J. F., Flenley D. C. Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. Br Med J. 1976 Feb 14;1(6006):365–367. doi: 10.1136/bmj.1.6006.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Massara F., Porta M., Martina V. The role of insulin in beta 2-receptor mediated hypokalemia. Clin Endocrinol (Oxf) 1985 Feb;22(2):227–230. doi: 10.1111/j.1365-2265.1985.tb01084.x. [DOI] [PubMed] [Google Scholar]
  17. Neville A., Palmer J. B., Gaddie J., May C. S., Palmer K. N., Murchison L. E. Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. Br Med J. 1977 Feb 12;1(6058):413–414. doi: 10.1136/bmj.1.6058.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Newman S. P., Clarke S. W. The proper use of metered dose inhalers. Chest. 1984 Sep;86(3):343–344. doi: 10.1378/chest.86.3.342. [DOI] [PubMed] [Google Scholar]
  19. Raij K-Alanko K., Muittari A., Härkönen M. Effect of salbutamol inhalations of plasma and urinary cyclic adenosine monophosphate levels in asthmatics and non-atopic controls. Scand J Respir Dis. 1976;57(5):223–230. [PubMed] [Google Scholar]
  20. Raimondi G., Rodriguez-Moncalvo J. J. Effects of beta-adrenergic agents on hypokalemia. Chest. 1987 Feb;91(2):288–289. doi: 10.1378/chest.91.2.288-b. [DOI] [PubMed] [Google Scholar]
  21. Rohr A. S., Spector S. L., Rachelefsky G. S., Katz R. M., Siegel S. C. Efficacy of parenteral albuterol in the treatment of asthma. Comparison of its metabolic side effects with subcutaneous epinephrine. Chest. 1986 Mar;89(3):348–351. doi: 10.1378/chest.89.3.348. [DOI] [PubMed] [Google Scholar]
  22. Smith S. R., Kendall M. J. Metabolic responses to beta 2 stimulants. J R Coll Physicians Lond. 1984 Jul;18(3):190–194. [PMC free article] [PubMed] [Google Scholar]
  23. Strauss M. H., Reeves R. A., Smith D. L., Leenen F. H. The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist. Clin Pharmacol Ther. 1986 Jul;40(1):108–115. doi: 10.1038/clpt.1986.146. [DOI] [PubMed] [Google Scholar]
  24. Struthers A. D., Reid J. L. Adrenaline causes hypokalaemia in man by beta 2 adrenoceptor stimulation. Clin Endocrinol (Oxf) 1984 Apr;20(4):409–414. doi: 10.1111/j.1365-2265.1984.tb03436.x. [DOI] [PubMed] [Google Scholar]
  25. Struthers A. D., Reid J. L., Whitesmith R., Rodger J. C. Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J. 1983 Jan;49(1):90–93. doi: 10.1136/hrt.49.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Struthers A. D., Whitesmith R., Reid J. L. Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet. 1983 Jun 18;1(8338):1358–1361. doi: 10.1016/s0140-6736(83)92140-2. [DOI] [PubMed] [Google Scholar]
  27. Svedmyr N. Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy. 1985 May-Jun;5(3):109–126. doi: 10.1002/j.1875-9114.1985.tb03409.x. [DOI] [PubMed] [Google Scholar]
  28. Tandon M. K. Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest. 1980 Mar;77(3):429–431. doi: 10.1378/chest.77.3.429. [DOI] [PubMed] [Google Scholar]
  29. Vincent H. H., Boomsma F., Man in't Veld A. J., Derkx F. H., Wenting G. J., Schalekamp M. A. Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):107–114. [PubMed] [Google Scholar]
  30. Vincent H. H., Man In't Veld A. J., Boomsma F., Wenting G. J., Schalekamp M. A. Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in man. Br J Clin Pharmacol. 1982 May;13(5):717–721. doi: 10.1111/j.1365-2125.1982.tb01442.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wang P., Clausen T. Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet. 1976 Jan 31;1(7953):221–223. doi: 10.1016/s0140-6736(76)91340-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES